Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
alpha lipoic acid + coenzyme Q10 is a combination of two naturally occurring mitochondrial antioxidants being investigated by The University of Texas Health Science Center at San Antonio for the treatment of vestibular function disorders in older adults. Alpha lipoic acid (ALA) serves as a cofactor for mitochondrial enzyme complexes and acts as a potent antioxidant, while coenzyme Q10 (CoQ10) is an essential component of the mitochondrial electron transport chain. The combination aims to mitigate oxidative stress and improve mitochondrial bioenergetics within the vestibular system to stabilize or improve balance and inner ear function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alpha lipoic acid + coenzyme Q10.